Results 181 to 190 of about 4,765,367 (286)

Self-report methods for the assessment of implementation determinants: Reflections on the CFIR user guide. [PDF]

Implement Sci
Woodfield MJ.
europepmc   +1 more source

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro, Shiwen Koay, Gordon T. Ingle, Patricia McNamara, Laura Watson, Fion Bremner, Valeria Iodice   +6 more
wiley   +1 more source

Implementation determinants of risk-stratified gestational diabetes mellitus screening in community-based women's peer groups in rural western Kenya. [PDF]

BMC Pregnancy Childbirth
Ogumbo R, Naanyu V, Ruhl L, Akiruga J, Kaluhi E, Chelagat S, Nyaboga H, Pastakia S.   +7 more
europepmc   +1 more source

Screening Routine Clinical Notes for Epilepsy Surgery Candidates Using Large Language Models

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Epilepsy surgery is severely underutilized despite proven efficacy, with substantial under‐referral of eligible patients in routine clinical practice. This study evaluated the potential role of large language models (LLMs) as decision‐support tools for screening unstructured clinical notes to identify epilepsy surgery candidates and ...
Uriel Fennig, Nadav Amir, Maya Schiller, Roni Loebenstein, Johnatan Nissan, Marina Boxer, Shany Guly Gofrit, Gal Goshen, Sándor Beniczky, Nicola Maggio   +9 more
wiley   +1 more source

One size fits all? A latent profile analysis to identify care professional subgroups based on implementation determinants. [PDF]

Implement Sci Commun
Dubbeldeman EM, van der Kleij RMJJ, Jong JCK, Diderich HM, Gerding ILL, Crone MR.   +5 more
europepmc   +2 more sources

Layers of complexity: a directed content analysis of implementation determinants for integrative group medical visits for patients with chronic pain in safety-net primary care. [PDF]

BMC Prim Care
Roth IJ, Tomczak P, Ferriola-Bruckenstein K, Gardiner P, Leeman J.   +4 more
europepmc   +1 more source

Feasibility and Implementation Determinants of a Structured Goal Setting and Goal Management System. [PDF]

Am J Occup Ther, 2023
Kang E, Chen J, Foster ER.
europepmc   +1 more source

Evaluation of Digital Technologies for Home‐Based Assessment in People With Amyotrophic Lateral Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller, Vanessa Vallejo, Mónica Povedano Panadés, Orla Hardiman, Véronique Danel‐Brunaud, Senda Ajroud‐Driss, Philippe Couratier, Jeremy Shefner, Anna Gokey, Mike DiCesare, Erin Lennox, Jens Praestgaard, Lucie Brujin, Peggy Allred, Ram Miller   +14 more
wiley   +1 more source

Fidelity, Implementation Determinants, and Patient-Level Outcomes Following Initial Implementation of NAVIGATE in the Early Psychosis Intervention-Spreading Evidence-Based Treatment (EPI-SET) Study. [PDF]

Schizophr Bull
Barwick M, Durbin J, Foussias G, Panzarella E, Saliba M, Brooks S, Stasiulis E, Dubrowski R, Kurdyak P, Sockalingam S, Addington D, Ampofo A, Anderson K, Bromley S, Choi M, Dahrouge S, Duda L, Jaouich A, Koegl C, Maxwell C, Miranda D, de Oliveira C, Polillo A, Primeau V, Riley J, Rossi D, Serhal E, Shakespeare J, Soklaridis S, Urajnik D, Kozloff N, Voineskos A.   +31 more
europepmc   +1 more source

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito, Kamal Benguerba, Ken Tsuchida, Kazushige Yazawa, Isao Tsumiyama, Hiromitsu Kayama, Sandra P. Reyna, Farid Khan, Richard S. Finkel   +8 more
wiley   +1 more source